Clinical management of a rare melanoma case arising from congenital melanocytic nevus

Ruixin Jiang; Yan Wang; Xuhui Ma; Xinyang Xuanyuan; Yanjie Zhang; Bin Jiang; Weizhen Zhang; Hanlin Zeng

doi:10.1016/j.gendis.2023.05.007

| Sign up

PDF (1.5 MB)

Cite

EndNote(RIS) BibTeX

Collect

Submit Manuscript

Show Outline

Outline

References

Show full outline

Hide outline

Rapid Communication | Open Access

Clinical management of a rare melanoma case arising from congenital melanocytic nevus

Ruixin Jiang^{^a^,^d^,¹}, Yan Wang^{^b^,¹}, Xuhui Ma^{^c^,¹}, Xinyang Xuanyuan^{^e}, Yanjie Zhang^{^a^,^d}, Bin Jiang^{^a}(), Weizhen Zhang^{^b}(), Hanlin Zeng^{^a^,^d}()

Department of Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201900, China

Department of Oncology, The Third People’s Hospital of Zhengzhou, Zhengzhou, Henan 450000, China

Department of Oral & Maxillofacial- Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200125, China

Shanghai Institute of Precision Medicine, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200125, China

Department of Dermatology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China

Peer review under responsibility of Chongqing Medical University.

¹ Co-first authors.

Show Author Information

References

Alikhan A, Ibrahimi OA, Eisen DB. Congenital melanocytic nevi: where are we now? Part Ⅰ. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis. J Am Acad Dermatol. 2012;67(4):495.e1–495.e17; quiz 512–4.

Crossref

Mir A, Agim NG, Kane AA, Josephs SC, Park JY, Ludwig K. Giant congenital melanocytic nevus treated with trametinib. Pediatrics. 2019;143(3):e20182469.

Crossref Google Scholar

Kinsler VA, O’Hare P, Jacques T, Hargrave D, Slater O. MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children. Br J Cancer. 2017;116(8):990–993.

Crossref Google Scholar

Weyand AC, Mody RJ, Rabah RM, Opipari VP. PD-1 inhibition in congenital pigment synthesizing metastatic melanoma. Pediatr Blood Cancer. 2018;65(1).

Crossref Google Scholar

Arance AM, de la Cruz-Merino L, Petrella TM, et al. Lenvatinib (Len) Plus Pembrolizumab (Pembro) for Patients (Pts) with Advanced Melanoma and Confirmed Progression on a PD-1 or PDL1 Inhibitor: Updated Findings of LEAP-004. ASCO Annual Meeting; 2021. Abstract 9504. 2021.

Crossref

Genes & Diseases

Volume 11 Issue 3,
May 2024

Article number: 101005

DOI: 10.1016/j.gendis.2023.05.007

Cite this article:

Jiang R, Wang Y, Ma X, et al. Clinical management of a rare melanoma case arising from congenital melanocytic nevus. Genes & Diseases, 2024, 11(3): 101005. https://doi.org/10.1016/j.gendis.2023.05.007